One snappy quote from the bench, and Centripetal's prized patent crumbles. The Federal Circuit just reminded everyone: doing nothing isn't patentably novel.
What if the Patent Eligibility Reform Act's big swing at fixing §101 ends up whiffing entirely? Two law profs have a sharper proposal—one that targets utility, not vague categories.
The Supreme Court just hit pause on a major copyright smackdown against an ISP. Grande Communications gets a second shot after SCOTUS's fresh take in Cox v. Sony.
Disney didn't just sue— it licensed. And in doing so, carved a Mandalorian path through AI's copyright chaos, leaving copycats like Midjourney in the dust.
Picture this: a final PTAB decision looming, claims holding firm. Then, bam—ex parte reexam filed 48 hours after a related loss. Welcome to patent warfare's latest cheat code.
Imagine your breakthrough cooling tech for sun-soaked screens, praised by rivals, licensed out, yet crushed in court. The nexus trap strikes again, exposing patent perils for modular innovations.
You're expecting wild revelations from patent inventor names. Nope – it's a parade of predictable guy-next-door monikers. Dig deeper, though, and the real power shift emerges.
The Federal Circuit just turned PTAB appeals into a high-wire act for patent challengers. One claim amendment, and your standing declaration? Obsolete.
President Trump's bold EO slaps 100% tariffs on imported patented pharmaceuticals. Drugmakers face a stark choice: move to America or pay up.
The Pro Codes Act is back, promising free access to safety codes—but at what cost to the standards machine? Opponents warn of crumbling innovation; backers cry foul on public domain myths.
Your garage invention goes viral. Big Tech copies it. You get nothing. That's the new normal strangling solo innovators — unless AI rewires patent monetization entirely.
A sweeping FAA flight restriction—framed as temporary but lasting 21 months—criminalizes drone journalism near immigration enforcement. Constitutional lawyers say it's indefensible.